BMC Med 13:225 Kanter J, Walters MC, Krishnamurti L, Mapara MY, Kwiatkowski JL, Rifkin-Zenenberg S, Aygun B, Kasow KA, Pierciey FJ, Bonner M (2022) Biologic and clinical efficacy of lentiglobin for sickle cell disease
Some patients may be candidates for switching from semaglutide to tirzepatide, but this decision should be made with a physician
Its a good fit for people who already understand GLP-1 treatment and dont need frequent provider check-ins or extensive coaching, making it a low-cost option for self-directed patients
As we grow older, cell renewal and repair slow down, which can be delayed by getting enough vitamins and nutrients, like vitamin B12
Pills are likely to be strongest in early treatment, needle-averse patients, maintenance therapy, and broad access markets